ID   OCI-AML-4
AC   CVCL_5224
SY   OCI/AML-4; OCI-AML4; OCI/AML4; OCI AML4; OCIAML4; Ontario Cancer Institute-Acute Myeloid Leukemia-4
DR   cancercelllines; CVCL_5224
DR   Cosmic; 787468
DR   Cosmic; 975290
DR   Cosmic; 1281345
DR   Cosmic; 1319547
DR   Cosmic; 2306233
DR   DepMap; ACH-001613
DR   DSMZ; ACC-729
DR   DSMZCellDive; ACC-729
DR   Wikidata; Q54931743
RX   PubMed=1715961;
RX   PubMed=29533902;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~24-30 hours (DSMZ=ACC-729).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DepMap=ACH-001613; DSMZ=ACC-729
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 12,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,24
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 19,24
ST   Penta D: 12
ST   Penta E: 10,14
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 24
//
RX   PubMed=1715961;
RA   Koistinen P.O., Wang C., Yang G.S., Wang Y.-F., Williams D.E.,
RA   Lyman S.D., Minden M.D., McCulloch E.A.;
RT   "OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and
RT   response to cytosine arabinoside.";
RL   Leukemia 5:704-711(1991).
//
RX   PubMed=29533902; DOI=10.1515/hsz-2017-0321;
RA   Drexler H.G., Pommerenke C., Eberth S., Nagel S.;
RT   "Hodgkin lymphoma cell lines: to separate the wheat from the chaff.";
RL   Biol. Chem. 399:511-523(2018).
//